Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch / plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Not Available
III
Zwerner, Jeffrey
NCT02448381
VICCDERM1572

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: